Limited Sources Justification and Approval0223_Final Version1_Redacted.pdf

This Limited Sources Justification and Approval document provides details for the Department of the Army Medical Command's solicitation for FDA approved Automated Coagulation Analyzers and associated reagents. The solicitation seeks to award a sole source contract to Siemens Healthcare Diagnostics Inc. for the analyzers and reagents, as they are the only manufacturer that can meet the Army's requirement for the specified equipment to maintain standardization across all military treatment facilities. The contract would have a one year base period of performance starting in April 2023 and two one-year option periods. The estimated total contract value including options is $6.5 million.